Bellevue Life Sciences Acquisition Corp.

NasdaqCM:BLAC Stock Report

Market Cap: US$45.5m

Bellevue Life Sciences Acquisition Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Peter Hwang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.7yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO

Peter Hwang (48 yo)

4.7yrs

Tenure

Mr. Kuk Hyoun Hwang, also known as Peter, is Chief Executive Officer and Director of Bellevue Life Sciences Acquisition Corp. since March 2020 and serves as its Executive Chairman. Mr. Hwang is the Managin...

Board Members

NamePositionTenureCompensationOwnership
Kuk Hwang
CEO & Executive Chairman4.7yrsno datano data
Jun Whang
Director4.3yrsno datano data
Jin Park
Independent Director1.8yrsno data0.49%
$ 225.2k
Geon Lee
Independent Directorless than a yearno datano data
Sang Kim
Independent Directorless than a yearno datano data

1.8yrs

Average Tenure

56yo

Average Age

Experienced Board: BLAC's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.